What is BroadPharm?
BroadPharm operates as a critical infrastructure provider for the global pharmaceutical and biotechnology industries. The company specializes in the synthesis and distribution of high-purity PEG linkers, Click Chemistry tools, and ADC linkers, which are essential components in modern drug development. By maintaining an extensive catalog of over 8,000 PEG linkers and 2,000 Click Chemistry reagents, BroadPharm serves as a vital partner for organizations engaged in complex bioconjugation and RNA synthesis projects. Their business model integrates high-volume manufacturing with bespoke custom services, effectively reducing the time-to-market for innovative therapeutic candidates. Through its commitment to quality and rapid supply chain execution, the firm has established itself as a cornerstone in the research and development ecosystem, facilitating advancements in antibody-drug conjugates and advanced drug delivery systems.
How much funding has BroadPharm raised?
BroadPharm has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in BroadPharm
PPP
Public-Private Partnership
What's next for BroadPharm?
The recent influx of capital is expected to catalyze BroadPharm's next phase of growth, particularly in the expansion of its bioconjugation service offerings and the optimization of its global logistics network. As the demand for sophisticated drug delivery lipids and specialized linkers continues to rise, the company is likely to prioritize the scaling of its manufacturing facilities to meet the rigorous requirements of late-stage clinical trials. Strategic focus will likely shift toward enhancing the efficiency of its R&D support services, ensuring that the firm remains at the forefront of the rapidly evolving biotech landscape. By leveraging this financial backing, BroadPharm is poised to solidify its leadership in the supply of high-purity chemical reagents, further cementing its role as an indispensable partner for global pharmaceutical innovators.
See full BroadPharm company page
